MACKENZIE FINANCIAL CORP - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 316 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.

Quarter-by-quarter ownership
MACKENZIE FINANCIAL CORP ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$384,896
+2.1%
10,2230.0%0.00%0.0%
Q2 2023$377,024
-22.5%
10,223
-19.8%
0.00%0.0%
Q1 2023$486,655
-35.9%
12,743
-4.5%
0.00%0.0%
Q4 2022$759,559
+69.2%
13,349
+17.5%
0.00%0.0%
Q3 2022$449,000
-83.6%
11,362
-81.7%
0.00%
-75.0%
Q2 2022$2,739,000
-10.6%
62,256
-19.0%
0.00%0.0%
Q1 2022$3,065,000
-5.4%
76,860
-4.6%
0.00%0.0%
Q4 2021$3,240,000
-1.8%
80,579
-0.6%
0.00%
-20.0%
Q3 2021$3,299,000
+174.7%
81,089
+206.7%
0.01%
+150.0%
Q2 2021$1,201,000
+33.0%
26,437
+22.0%
0.00%
+100.0%
Q1 2021$903,000
+100.7%
21,667
+26.6%
0.00%0.0%
Q3 2020$450,000
-39.9%
17,120
-38.7%
0.00%
-50.0%
Q2 2020$749,000
-0.9%
27,942
-33.5%
0.00%0.0%
Q1 2020$756,000
+261.7%
42,018
+255.8%
0.00%
+100.0%
Q4 2019$209,000
-27.7%
11,810
-29.8%
0.00%0.0%
Q2 2019$289,000
+6.6%
16,8200.0%0.00%0.0%
Q1 2019$271,00016,8200.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Third Security, LLC 14,092,771$256,066,00016.64%
BB BIOTECH AG 8,247,860$149,864,0003.97%
MSD Partners, L.P. 2,245,000$40,792,0003.07%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 428,633$5,969,0002.84%
First Light Asset Management, LLC 885,523$16,090,0002.60%
SNYDER CAPITAL MANAGEMENT L P 2,387,350$43,378,0001.93%
Sterling Global Strategies LLC 22,000$400,0001.74%
Taylor Wealth Management Partners 221,380$4,022,0001.71%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,228,399$167,680,0001.68%
DOHENY ASSET MANAGEMENT /CA 124,393$2,260,0001.18%
View complete list of HALOZYME THERAPEUTICS INC shareholders